Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002–2004)
- 1 September 2006
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 12 (9) , 844-852
- https://doi.org/10.1111/j.1469-0691.2006.01550.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) lineHeart & Lung, 2005
- Vancomycin-resistant enterococci: consequences for therapy and infection controlClinical Microbiology & Infection, 2005
- Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwideDiagnostic Microbiology and Infectious Disease, 2004
- Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)Diagnostic Microbiology and Infectious Disease, 2004
- Methicillin-resistantStaphylococcus aureusin Europe, 1999–2002Emerging Infectious Diseases, 2004
- The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure InfectionsClinical Infectious Diseases, 2004
- Daptomycin: Another Novel Agent for Treating Infections Due to Drug‐Resistant Gram‐Positive PathogensClinical Infectious Diseases, 2004
- Daptomycin: a novel lipopeptide antibioticClinical Microbiology Newsletter, 2002
- Development of daptomycin for Gram-positive infectionsJournal of Antimicrobial Chemotherapy, 2000
- Methicillin-ResistantStaphylococcus aureus in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994